CAH vs SRTA
CAH: Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies, hospitals, and health systems globally. SRTA: A time-critical logistics and clinical services provider offering integrated air/ground organ transport, surgical organ recovery, and cardiac perfusion solutions to the U.S. transplant ecosystem.
Side-by-side fundamentals
| Metric | CAH | SRTA | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $220.54 | $5.08 | |
| Market cap as of 2026-07-23 | $53.0B | $438M | |
| P/E as of 2026-07-23 | 34.07 | 9.33 | SRTA lower |
| PEG as of 2026-07-23 | 2.07 | n/a | |
| Net margin as of 2026-07-23 | +0.6% | +18.5% | SRTA higher |
| Gross margin as of 2026-07-23 | +3.8% | -39.7% | CAH higher |
| Operating margin as of 2026-07-23 | +0.9% | -7.8% | CAH higher |
| ROE as of 2026-07-23 | +37.2% | +17.5% | CAH higher |
| ROA as of 2026-07-23 | +2.8% | +15.1% | SRTA higher |
| Debt / equity as of 2026-07-23 | 5.65 | 0.00 | SRTA lower |
| Revenue growth (YoY) as of 2026-07-23 | +12.9% | +19.6% | SRTA higher |
| Revenue CAGR (3y) SEC XBRL | +7.1% | +10.5% | SRTA higher |
| Dividend yield as of 2026-07-23 | +0.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.53 | 2.27 | |
| 1-year return as of 2026-07-22 close | +43.2% | +12.4% | CAH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.